In line with the agreements between Uzbekistan and Belarus, a carbopenems (antibiotics) production site is planned to set up in Tashkent’s Yunusabad district.
The executives of the Belarusian company in January 2019 opened a legal entity - IE LLC BELFARM and prepared a conceptual project of production.
The investor undertakes to fulfill investment and social obligations for a period of 6 years. The company must attract foreign direct investment in an equivalent of at least $ 10 million.
The project is scheduled to be implemented by selling at zero-cost buildings and structures with a total area of 14,625 sqm with the adjacent territory with a total area of 2 hectares with the imposition of investment and social obligations.
